# EDGAR Filing Document

**Accession Number:** 0001917375
**File Stem:** 9999999994-23-000119
**Filing Date:** 2023-3
**Character Count:** 1309
**Document Hash:** ff80da7a96b50db44eff1cdeca0c197a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**9999999994-23-000119.hdr.sgml**: 20230321

**ACCESSION NUMBER**: 9999999994-23-000119

**CONFORMED SUBMISSION TYPE**: QUALIF

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230320

**DATE AS OF CHANGE**: 20230321

**EFFECTIVENESS DATE**: 20230320

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ONCOLYZE, INC.
- **CENTRAL INDEX KEY:** 0001917375
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** QUALIF
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 024-11890
- **FILM NUMBER:** 23747750

**BUSINESS ADDRESS:**
- **STREET 1:** 845 UN PLAZA, APT. 61B
- **STREET 2:** ATTN: STEVEN J. EVANS, M.D.
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** 917-670-5933

**MAIL ADDRESS:**
- **STREET 1:** 845 UN PLAZA, APT. 61B
- **STREET 2:** ATTN: STEVEN J. EVANS, M.D.
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

### UNITED STATES
### SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## Notice of Qualification

**Date:** March 20, 2023

**Time:** 14:00:00

**Form Type:** 1-A POS

---

**CIK:** 0001917375

**Company Name:** ONCOLYZE, INC.

**File Number:** 024-11890